ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 696921 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 696921; 2) Community: the network communities that were significantly associated with the response to NSC 696921; 3) Molecule: the relationships between components within communities and NSC 696921; 4) MDR: the compounds that were significantly associated with the NSC 696921.

NSC Compound Enrichment Correlation
NSC 732851 1-[3-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-2-chloro-5-trifluoromethylbenzene 0.000104553642000969 0.40190791
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.00010455364200097 0.43370086
NSC 633713 N.ALPHA.-(4-AMINO-4-DEOXYLPTEROYL)-N.DELTA.-HEMIPHTHALOYL-L-ORNITHINE 0.00010455364200097 0.32276805
NSC 673415 Null 0.00010455364200097 0.41614985
NSC 762934 Null 0.000132595565954569 -0.22865769
NSC 363812 Tetraplatin 0.00013259556595457 0.44677739
NSC 674066 stereoisomer of NSC 674067-P 0.00013259556595457 0.36884714
NSC 682824 Propanimidoyl chloride, N-[[[(3-chloro-4-fluorophenyl) amino]carbonyl]oxy]-2-methyl- 0.00013259556595457 0.62957721
NSC 697677 Null 0.000174252554411806 0.18783985
NSC 709971 7H-Thieno[3',4':3,4]cyclopent[1,2-d]oxazol-7-one, 4,6-dibromo-1,2,3a,7a-tetrahydro-2-thioxo-, CIS- 0.000174252554411806 0.51422943
Total:170  Current:1    [First] [Prev] [Next] [Last]